Rwanda Accepts Favipiravir for Early Onset Mild COVID-19 Adding to a Growing List of Nations
The eastern African nation of Rwanda appears to be joining dozens of others nations worldwide and accepting Favipiravir as a […]
The eastern African nation of Rwanda appears to be joining dozens of others nations worldwide and accepting Favipiravir as a […]
Appili Therapeutics Inc. (TSX: APLI, OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious […]
Based on preclinical research in cell cultures and animals, a team of investigators at the University of Nottingham in England […]
A research team led by the prestigious University of California, San Francisco (UCSF) reveals that a drug known as Aplidin […]
Yet another nation has opted to embrace the antiviral drug Favipiravir (Avigan) as a treatment for early onset COVID-19. Approved […]
A growing number of articles, papers and discussions point out that despite the great news of vaccines approved for emergency […]
Russia’s Direct Investment Fund (RDIF), an active participant in funding the development of therapies and vaccines for that nation in […]
Japanese health authorities are struggling to reach a decision as to whether favipiravir (Avigan) is effective as treatment for COVID-19 […]
A large group of researchers from Indian and Malaysian academic medical centers, led by Mainul Haque, Pharmacology Unit, Faculty of […]
Kansas State University College of Veterinary Medicine virologists are on a mission to fast track COVID-19 vaccines. But how well will […]